SCHEMBL6403796

SCHEMBL6403796

COCCn1c(S)nnc1COc1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.57
RAB9A P51151 2/20 0.45
TP53 P04637 2/20 0.45
NPC1 O15118 1/20 0.44
KMT2A Q03164 1/20 0.44
ADAMTS5 Q9UNA0 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
POLB P06746 1/20 0.42
ADRB2 P07550 1/20 0.42
HTT P42858 1/20 0.42
RECQL P46063 1/20 0.41
CDK2 P24941 4/20 0.41
CDK1 P06493 3/20 0.41
CCNB1 P14635 3/20 0.41
ADAMTS4 O75173 1/20 0.41
ALDH1A1 P00352 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404305 0.77 ALDH1A1 (0.55) TSHRRAB9ATP53NPC1KMT2A
SCHEMBL6405035 0.73 MAPT (0.53) TSHRRAB9ATP53NPC1KMT2A
SCHEMBL20952225 0.72 ALDH1A1 (0.35) TSHRALDH1A1TDP1
SCHEMBL28043506 0.70 ALDH1A1 (0.58) RAB9ANPC1KMT2AADAMTS5SMN1; SMN2
SCHEMBL10012011 0.69 TSHR (0.52) TSHRRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL6410076 0.68 KMT2A (0.48) TSHRRAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL14112934 0.66 TSHR (0.33) TSHRKMT2AALDH1A1KDM4E
SCHEMBL14207930 0.66 DRD4 (0.50) RAB9ANPC1SMN1; SMN2MAOB
SCHEMBL14557022 0.65 GLA (0.46) TSHRSMN1; SMN2RECQLALDH1A1KDM4E
SCHEMBL9424127 0.65 MAOB (0.57) SMN1; SMN2HTTMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT TSHR 3470/4885RAB9A 4278/4885TP53 1524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.